Growth Insights on the Global Lung Cancer Surgery Market Driven by Precision Oncology The global lung cancer surgery market is projected to expand at a 5.9% CAGR, driven by increased adoption of robotic and minimally invasive techniques. Key players Medtronic and Intuitive Surgical lead this growth.

Growth Insights on the Global Lung Cancer Surgery Market Driven by Precision Oncology #None #Medtronic #Lung_Cancer #Intuitive_Surgical

Medtronic's Stealth AXiS™ Surgical System: A Game-Changer for Cranial and ENT Procedures Medtronic has received FDA clearance for the Stealth AXiS™ Surgical System, revolutionizing cranial and ENT procedures with advanced navigation and robotics.

Medtronic's Stealth AXiS™ Surgical System: A Game-Changer for Cranial and ENT Procedures #USA #FDA #Medtronic #Galway #Stealth_AXiS™

Medtronic impulsa la innovación colaborativa para cerrar la brecha de género en salud y tecnología El evento "Hackeando la brecha: tecnología, mujer y salud", organizado por Fenin, ha reunido a expertos del ámbito clínico, tecnológico y social para cocrear soluciones

#Industria | 🔹 #Medtronic participa en el hackathon “Hackeando la brecha”, organizado por #Fenin, cocreando soluciones para reducir la brecha de género en #salud

Healthcare and Robotics Week 2026

Healthcare and Robotics Week 2026

Healthcare and Robotics Week 2026

Healthcare and Robotics Week 2026

Thank you to MassRobotics, sponsors, and our fellow Healthcare Robotics Startup Catalyst cohort members for an inspiring Healthcare and Robotics Week!

@mitsubishi-elect.bsky.social | #Festo | #Novanta | #Medtronic | #MassRobotics #MedTech #HealthcareInnovation #WearableRobotics #Pittsburgh #Boston

Medtronic Partners with Merit to Distribute Back Pain Device Medtronic (MDT) and Merit (MMSI) announced on Mar 24, 2026 a U.S. distribution agreement; monitor 8-Ks for revenue-sharing terms and adoption milestones.

Medtronic Partners with Merit to Distribute Back Pain Device: Medtronic (MDT) and Merit (MMSI) announced on Mar 24, 2026 a U.S. distribution agreement; monitor 8-Ks for revenue-sharing terms and adoption milestones. 👈 Read full analysis #Medtronic #Merit #BackPain #MedTech #HealthcareInnovation

Medtronic and Merit Medical Systems Partner to Transform Chronic Pain Treatment with ViaVerte™ System Medtronic and Merit Medical Systems have partnered to introduce the FDA-cleared ViaVerte™ system for chronic back pain relief, enhancing patient treatment options.

Medtronic and Merit Medical Systems Partner to Transform Chronic Pain Treatment with ViaVerte™ System #Ireland #Medtronic #Galway #Merit_Medical #ViaVerte

Medtronic's OmniaSecure™: A Breakthrough in Cardiac Defibrillation Technology Medtronic has pioneered the first FDA-approved defibrillation lead for conduction system pacing, enhancing patient treatment options.

Medtronic's OmniaSecure™: A Breakthrough in Cardiac Defibrillation Technology #USA #Minneapolis #Medtronic #OmniaSecure #Defibrillator_Lead

MiniMed se separa de Medtronic y comienza a operar como empresa independiente mediante salida a bolsa MiniMed, la división de diabetes de Medtronic especializada en bombas de insulina y sistemas de monitorización continua de glucosa, ha iniciado oficialmente su etapa como empresa independiente el 6 de marzo de 2026. Esta separación se materializó a través de una oferta pública inicial (IPO) en el Nasdaq bajo el símbolo 'MMED', donde se recaudaron alrededor de 560 millones de dólares con la emisión de 28 millones de acciones a 20 dólares cada una. El objetivo principal de esta independencia es aumentar la agilidad estratégica, acelerar la innovación y centrarse exclusivamente en el desarrollo de tecnologías avanzadas para la diabetes, como sistemas híbridos de páncreas artificial, algoritmos mejorados y soluciones digitales de gestión glucémica. Aunque Medtronic mantiene aproximadamente un 90 % de la propiedad tras la operación, MiniMed opera ya como entidad separada. Los proveedores deben actualizar sus procesos de facturación y pedidos con las nuevas entidades legales, pero se garantiza la continuidad en contratos, suministro de productos y especificaciones técnicas existentes. Esta reestructuración responde a la tendencia del sector sanitario hacia compañías más especializadas, lo que podría impulsar inversiones en I+D, nuevas alianzas con empresas tecnológicas y farmacéuticas, y avances rápidos en automatización del control de la glucosa. El mercado de tecnologías para la diabetes experimenta una fuerte evolución con progresos en monitorización continua y sistemas automatizados, y MiniMed busca posicionarse como líder especializado en este ámbito.

MiniMed se separa de Medtronic y comienza a operar como empresa independiente mediante salida a bolsa

🤖 IA: No es clickbait ✅
👥 Usuarios: No es clickbait ✅

#diabetes #medtronic #minimed

Ver resumen IA completo:

First Insurance-Covered Treatment with Accurian Pain Management System Launched The Accurian pain management system, developed by Yukaria, has been successfully used in Japan for insurance-covered procedures, benefiting many patients.

First Insurance-Covered Treatment with Accurian Pain Management System Launched #Japan #Tokyo #Medtronic #Yukaria #Accurian

Medtronic's Acquisition of Scientia Vascular: A Game-Changer in Neurovascular Care Access Medtronic signs a $550 million deal to acquire Scientia Vascular, enhancing its neurovascular portfolio and improving access to vital therapeutic products.

Medtronic's Acquisition of Scientia Vascular: A Game-Changer in Neurovascular Care Access #Ireland #Medtronic #Galway #Scientia_Vascular #Neurovascular_Care

MiniMed Successfully Closes Initial Public Offering, Securing Over Half a Billion Dollars MiniMed Group, Inc. has officially closed its initial public offering, raising approximately $538 million, with shares trading at $20.00 each.

MiniMed Successfully Closes Initial Public Offering, Securing Over Half a Billion Dollars #United_States #Medtronic #IPO #Northridge,_California #MiniMed

MiniMed Group, Inc. Takes a Major Step on Nasdaq with Its IPO Launching Today MiniMed Group, Inc. officially starts trading on Nasdaq as it embarks on its journey as a standalone entity after a significant IPO event.

MiniMed Group, Inc. Takes a Major Step on Nasdaq with Its IPO Launching Today #NASDAQ #Ireland #Medtronic #Galway #MiniMed

MiniMed Group Sets Price for Initial Public Offering of Stock MiniMed Group, Inc. has announced the pricing for its initial public offering, marking a significant milestone as it prepares for public trading on Nasdaq.

MiniMed Group Sets Price for Initial Public Offering of Stock #United_States #Northridge #Medtronic #IPO #MiniMed

MiniMed Group Pricing Announced for Initial Public Offering and What It Means MiniMed Group, Inc. has set the price for its initial public offering, expected to boost the company's growth in the insulin delivery market.

MiniMed Group Pricing Announced for Initial Public Offering and What It Means #United_States #Medtronic #IPO #MiniMed_Group #North_Ridge

Medtronic Declares Fourth Quarter Dividend for Fiscal Year 2026 On March 5, 2026, Medtronic's board authorized a cash dividend of $0.71 per share for the fourth quarter, continuing a tradition of growth.

Medtronic Declares Fourth Quarter Dividend for Fiscal Year 2026 #Dividend #Ireland #Medtronic #Galway #fiscal_year_2026

The Growing Peripheral Vascular Devices Market and The Surge in Demand for Minimally Invasive Treatments The global peripheral vascular devices market is projected to grow at a CAGR of ~6% until 2032, driven by the rising demand for minimally invasive treatments and aging demographics.

The Growing Peripheral Vascular Devices Market and The Surge in Demand for Minimally Invasive Treatments #None #Boston_Scientific #Medtronic #Peripheral_Vascular_Devices

Medtronic's CFO to Address Investors at Major Conferences This March Thierry Piéton, Medtronic's CFO, is set to participate in prominent investor conferences, discussing the company's strategic vision and innovations.

Medtronic's CFO to Address Investors at Major Conferences This March #healthcare_technology #Ireland #Medtronic #Galway #Thierry_Piéton

Fundamental analysis of $MDT (Medtronic plc) based on financial data and reported results.

#MDT #Medtronic

Medtronic Launches Innovative MiniMed Go Smart MDI System in Europe Medtronic unveils the MiniMed Go Smart MDI system in Europe, integrating Simplera sensor for enhanced diabetes management. This innovation aims to aid users in their daily injections and offers real-time insights.

Medtronic Launches Innovative MiniMed Go Smart MDI System in Europe #None #Europe #Medtronic #MiniMed_Go #Simplera_sensor

Spread the word: Medtronic allows ICE to use their parking lots as staging areas. So much for their concern for public health. #MDT #Medtronic

Medtronic's Stealth AXiS™ System: Revolutionizing Spine Surgery with FDA Approval Medtronic's Stealth AXiS™ surgical system gains FDA clearance, merging planning, navigation, and robotics to enhance spine surgery outcomes.

Medtronic's Stealth AXiS™ System: Revolutionizing Spine Surgery with FDA Approval #Ireland #Medtronic #Spine_Surgery #Galway #Stealth_AXiS™

Knobbe Martens Secures $381 Million Win for Applied Medical Against Medtronic In a landmark antitrust case, Knobbe Martens achieves a significant verdict of $381 million for Applied Medical against Medtronic, reflecting the vital role of competition in healthcare.

Knobbe Martens Secures $381 Million Win for Applied Medical Against Medtronic #United_States #Irvine #Medtronic #Applied_Medical #Knobbe_Martens

A screenshot of the Medtronic page on DigiBete. Use the link on the post to find out more

💥Take a look at our fab Medtronic page today!!💥
Learn more on the #DigiBete website about what insulin pump therapy is, who can use it & what the Medtronic hybrid #closedloop 780G system does.

🔗https://ow.ly/vVNe50Y8Imu

#Ad #T1D #Type1diabetes#HCL #Hcltech #medtronic

Medtronic's Strategic Move: Acquisition of CathWorks to Enhance Cardiovascular Solutions Medtronic plans to acquire CathWorks, enhancing its capabilities in cardiovascular healthcare through innovative technology and partnership.

Medtronic's Strategic Move: Acquisition of CathWorks to Enhance Cardiovascular Solutions #Ireland #Medtronic #Galway #CathWorks #FFRangio

What about all the other companies like #Medtronic

Medtronic Marks Milestone with Affera Sphere-360 Catheter Launch for AFib Treatment Medtronic announces CE Mark approval in Europe and initiation of the Horizon 360 IDE trial for its Sphere-360 catheter, revolutionizing AFib treatment.

Medtronic Marks Milestone with Affera Sphere-360 Catheter Launch for AFib Treatment #Ireland #Medtronic #Galway #Affera #Sphere-360

It's offensive & cowardly that these #Minnesota companies are NOT demanding justice in the murder of #ReneeNicoleGood: #Target #BestBuy #USBancorp #3MCompany #Cargill #Medtronic #GeneralMlls #Ecolab #XcelEnergy #LandO'Lakes

It's the regular folks in MN & around the world who ARE demanding justice.